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Reducing stigma among healthcare
providers to improve mental health
services (RESHAPE): protocol for a pilot
cluster randomized controlled trial of a
stigma reduction intervention for training
primary healthcare workers in Nepal
Brandon A. Kohrt1,2,3*, Mark J. D. Jordans2,4, Elizabeth L. Turner1,5, Kathleen J. Sikkema1,6, Nagendra P. Luitel2,
Sauharda Rai1,2,3, Daisy R. Singla7,8, Jagannath Lamichhane9, Crick Lund4,10 and Vikram Patel11,12,13

Abstract
Background: Non-specialist healthcare providers, including primary and community healthcare workers, in low- and
middle-income countries can effectively treat mental illness. However, scaling-up mental health services within existing
health systems has been limited by barriers such as stigma against people with mental illness. Therefore, interventions
are needed to address attitudes and behaviors among non-specialists. Aimed at addressing this gap, REducing Stigma
among HealthcAre Providers to ImprovE mental health services (RESHAPE) is an intervention in which social contact
with mental health service users is added to training for non-specialist healthcare workers integrating mental health
services into primary healthcare.
Methods: This protocol describes a mixed methods pilot and feasibility study in primary care centers in Chitwan, Nepal.
The qualitative component will include key informant interviews and focus group discussions. The quantitative
component consists of a pilot cluster randomized controlled trial (c-RCT), which will establish parameters for a
future effectiveness study of RESHAPE compared to training as usual (TAU). Primary healthcare facilities (the
cluster unit, k = 34) will be randomized to TAU or RESHAPE. The direct beneficiaries of the intervention are
the primary healthcare workers in the facilities (n = 150); indirect beneficiaries are their patients (n = 100). The
TAU condition is existing mental health training and supervision for primary healthcare workers delivered through the
Programme for Improving Mental healthcarE (PRIME) implementing the mental health Gap Action Programme
(mhGAP). The primary objective is to evaluate acceptability and feasibility through qualitative interviews with
primary healthcare workers, trainers, and mental health service users. The secondary objective is to collect
quantitative information on health worker outcomes including mental health stigma (Social Distance Scale),
clinical knowledge (mhGAP), clinical competency (ENhancing Assessment of Common Therapeutic factors,
ENACT), and implicit attitudes (Implicit Association Test, IAT), and patient outcomes including stigma-related
barriers to care, daily functioning, and symptoms.
(Continued on next page)
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Discussion: The pilot and feasibility study will contribute to refining recommendations for implementation of
mhGAP and other mental health services in primary healthcare settings in low-resource health systems. The
pilot c-RCT findings will inform an effectiveness trial of RESHAPE to advance the evidence-base for optimal
approaches to training and supervision for non-specialist providers.
Trial registration: ClinicalTrials.gov identifier, NCT02793271
Keywords: Attitudes, Competence, Low- and middle-income countries, Mental health, Non-specialists, Primary
care, Service users, Task-shifting, Training, Stigma,

Background
Research trials have shown that non-specialist providers—individuals with no formal training in mental health
including primary care and community health workers—can effectively deliver mental health services in
low-resource settings in low- and middle-income countries (LMIC) [1, 2]. However, scaling-up these services
into government and non-government health systems
requires addressing numerous implementation barriers.
One limiting factor is the incomplete uptake from training into service provision and lack of fidelity to
evidence-based practice (EBP) among non-specialists.
This is due, in part, to negative attitudes and other
forms of stigma among health workers against persons
with mental illness [3, 4].
Attitudes among providers are critical in influencing
the adoption of EBP [5–10]. When non-specialist and
specialist health workers have negative attitudes toward
patients, they are less likely to implement EBP, they
spend less time with patients with mental illness, and
they allow fewer opportunities for patients and their
families to share concerns [11–14]. With similarities to
high-income countries (HIC), negative beliefs among
healthcare workers in LMIC are widespread including
beliefs that people with mental illness are violent, they
are to blame for their illnesses, that they can only be
treated by specialists, and that treating a person with
mental illness can transmit the illness to the healthcare
provider [4, 15–19]. Moreover, studies in LMIC have
documented that health workers often choose not to
provide mental healthcare because of the stigma against
mental illness [20–25]. Furthermore, the risk of providers having negative attitudes increases when engagement in new tasks is perceived as involuntary [26]. This
may be commonplace in task-sharing (also referred to as
task-shifting), where non-specialists perceive obligatory
engagement with new responsibilities imposed by government and non-governmental institutions as adding to
existing service burdens [5].
Interventions are needed to address attitudes among
non-specialist providers to enhance delivery of quality
mental healthcare. Improving provider attitudes and competence can increase the likelihood that interventions are

scaled up and delivered with fidelity. Lessons learned from
the field of HIV/AIDS treatment suggest that reducing
healthcare worker stigma can improve care and patient
outcomes. Training programs for healthcare workers that
integrate stigma-awareness and stigma reduction techniques have been successfully implemented in HIV counseling in sub-Saharan African and other low-resource settings
[27, 28]. At a national referral hospital in Tanzania, healthcare workers who participated in a stigma reduction
program in addition to HIV/AIDS counseling training had
more positive patient outcomes, including increased uptake
of antiretroviral treatment among patients as well as higher
disclosure rates, compared to healthcare workers who were
only trained in HIV counseling [29]. Similar results demonstrating improved patient care (e.g., increased access to
HIV prevention programs, increased awareness of and
reduced engagement in discriminatory practices in hospitals) through the reduction of health worker stigma have
been achieved in settings ranging from Vietnam to the
Southeast United States [28, 30, 31].
Unlike trials in the field of HIV/AIDS care, there is a
dearth of rigorous anti-stigma trials in the field of
mental health in LMIC and a global lack of information
on sustained changes in attitudes and clinical competence [4, 15, 32], even though stigma has been demonstrated to be such an important barrier for mental
healthcare [33–37]. A review of the literature on stigma
research in LMIC identified few intervention studies (n
= 27), of which only six reported any outcomes and none
included long-term follow-up of participants, and the
authors concluded that social contact interventions have
not been sufficiently evaluated for effectiveness [15].
To address this gap, we propose REducing Stigma among
HealthcAre Providers to improvE mental health services
(RESHAPE) as an intervention for non-specialist healthcare
providers (specifically, primary healthcare workers) in
which social contact with mental health service users is
added to training programs. RESHAPE is grounded in the
increasing evidence that contact-based interventions can
improve attitudes and decrease stigma [4, 32, 38]. Contact
interventions include facilitated interaction with mental
health service users, such as mental health service users
participating in training by giving testimonials and sharing
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social activities [39, 40] and reflect a broader literature of
patient-centered research [41]. Contact interventions
perform better than education interventions with in-person
contact showing a greater mean effect size for attitudinal
change and behavioral intentions compared to video
contact; however, among adolescents, only in-person social
contact outperforms education, whereas video contact has
small mean effect sizes [38].
The RESHAPE implementation strategy is built on this
and other evidence from HIV for stigma reduction among
health workers including multiple forms of social contact
and testimony from trained mental health service users, as
well as myth busting, teaching communication skills to address stigma, a recovery emphasis, and use of enthusiastic
facilitators [4, 32, 38, 42]. We hypothesize that the
RESHAPE interventions reduce stigmatizing attitudes and
subsequently leads to better clinical competency, improved
quality of care, and optimal patient outcomes through a
mechanism of social engagement with service users during
training. Engagement with service users, who are trained
as RESHAPE facilitators, will lead to greater recognition of
patients as human beings worthy of attention and clinical
effort, which are components of common factors in mental
healthcare that contribute to intervention effectiveness
across different modalities of treatment [43–45]. Moreover,
the participation of service users fosters beliefs that mental
illnesses are treatable and normalize the experience of
living with a mental illness. Improved attitudes and
enhanced delivery of evidence-based treatments can then
be mutually reinforcing [46] leading to improved patient
outcomes, and over time, experiences with positive patient
outcomes will further reinforce improved knowledge and
positive explicit and implicit attitudes (see Fig. 1). Ultimately, RESHAPE is designed as a potential addition to any
mental health training for non-specialists to improve
provider attitudes and competence as a pathway of
improving patient outcomes.
Pilot studies are needed to address issues related to
process, resources, management, or scientific approaches
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[47, 48]. In the case of the RESHAPE trial, we are
conducting a pilot for process reasons, such as determining recruitment and retention of mental health service
users to participate as facilitators and retention of health
workers when trained by mental health services users.
Additionally, we need to determine the ability of a full
trial to capture both direct benefits on health workers
and indirect benefits on patients, with the latter necessitating feasible recruitment and retention procedures.
The second justification for the pilot study is scientific
questions with regard to the safety of mental health
service users participating as facilitators in RESHAPE
trainings and issues related to amount of acceptable
participation by service users. An additional benefit in
the scientific domain is obtaining context-specific preliminary estimates of the degree of clustering of outcomes by health facility and of possible trajectories of
outcomes over time, which is relevant for the design of
the full cluster trial.
Objectives

The purpose of the current protocol is to describe a pilot
and feasibility study employing a cluster randomized trial
(c-RCT) with two arms incorporating qualitative and quantitative data collection. The two trial arms are training as
usual (TAU) and RESHAPE. We will assess the acceptability and feasibility of the RESHAPE intervention, and we will
collect data for design of a full-scale effectiveness c-RCT of
RESHAPE compared to TAU. The pilot and feasibility
objectives (see Table 1) include the following:
1. Establish feasibility and acceptability of involving
mental health service users in mental healthcare
training and supervision (primary objective);
2. Establish a fidelity evaluation system, and
characterize degree of fidelity and degree of
contamination;
3. Demonstrate adequacy of randomization procedures;
4. Determine recruitment and retention rates;

Fig. 1 Conceptual model for REducing Stigma among HealthcAre Providers to improvE mental health services (RESHAPE). The RESHAPE intervention
utilizes social contact with persons with mental illness who are trained as RESHAPE co-facilitators to reduce explicit stigmatizing attitudes as well as
enhance uptake of knowledge, reduce negative implicit biases, and subsequently improve clinical competence, quality of care, and patient outcomes
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Table 1 Pilot study objectives
Domains

Research questions

Hypotheses

Methods

Participants

1-1. Feasibility and
acceptability of
intervention

Do mental health expert trainers,
primary care trainees, and
mental health service users find
it acceptable for trained mental
health service users to
participate as co-facilitators in
training and supervision?

Key stakeholders will find
participation of trained mental
health service users
acceptable.

● Qualitative interviews with
mental health expert trainers,
primary care trainees, trained
mental health service users,
and research staff
● Process notes from trainings
and supervision sessions

Mental health expert
trainers, primary care
trainees, trained mental
health service users,
research staff

1-2. Fidelity and
contamination of
intervention

Can fidelity be feasibly and
Fidelity can be feasibly and
reliably assessed? What degree
reliably assessed with a
of fidelity to RESHAPE is
structured tool, which will
achievable? Can contamination be also inform assessment of
captured through fidelity and
contamination
other assessments?

● Use of fidelity assessment tool
by research staff; target is fidelity
of 75% of items on the fidelity
checklist
● Qualitative interviews with
mental health expert trainers,
primary care trainees, trained
mental health service users,
and research staff
● Process notes and videos
from trainings and supervision
sessions

Mental health expert
trainers, primary care
trainees, trained mental
health service users,
research staff

1-3. Randomization

Are there biases in the
randomization procedure for
primary care workers or patients?
How could randomization be
adjusted based on contamination
findings?

Simple randomization will be
adequate

● Tabulation of descriptive
summaries for baseline
characteristics comparing
the two groups
● Trainee demographics
(educational/professional
qualifications, age, gender,
prior mental health exposure,
years of experience)
● Health facility log book review
for patient demographics (age,
gender, disorder, number of visits)

Primary care trainees
and patients

1-4. Recruitment
and retention

Can adequate numbers of
mental health service users be
recruited, trained, and retained
to serve as facilitators? Can
adequate numbers of primary
care workers and patients be
recruited and retained for
outcome analyses?

Mental health service users
can be trained and retained
throughout to sustain ongoing
social engagement throughout
the study. Primary care
workers and patients will need
to be over-recruited to
account for population
mobility, loss to follow-up,
and professional transfers.

● Process outputs: mental
health service users (number
trained, number participating
in training, number participating
in supervision), target is 50% service
user retention; primary care worker
trainees (number available in facilities,
number at trainings, number at
supervision sessions; number
completing assessments), target
is 66% health workers completion
of assessment at 16 months; patients
(number attending facilities, number
of sessions received, number consenting,
number completing assessments), target
is 66% patient completion of 6-month
follow-up assessment
● Qualitative interviews with primary
care trainees, trained
mental health service users,
patients, and research staff

Primary care trainees,
trained mental health
service users, patients,
research staff

1-5. Acceptability,
feasibility, and
validity of measures

Are the assessment tools feasible
to administer and understand
for primary care workers and
patients at the planned intervals?
Is there expected interinstrument validity?

The measures will demonstrate
adequate acceptability,
feasibility, and validity for
subsequent trials.

● Tool completion rate, time for
Primary care trainees,
completion, number of missing
patients, and research
items; target is fewer than 15%
staff
missing items on measures
● Correlations among instruments
● Cognitive interviewing for transcultural
validity

1-6. Instrument
statistical
characteristics in
cluster design

What is the between and within
cluster variance for outcome
measures?

Clustering of outcomes within
health facilities supports need
for cluster randomized design

● Statistical analyses of outcome
measures

1-7. Ethics and safety Does the research pose harm to
of trial
primary care workers, patients, or
mental health service users,
facilitators and are these harms
adequately prevented,
documented, and addressed?

A subsequent larger scale trial
can be conducted using the
ethical and safety standards
piloted

● Qualitative interviews
Primary care trainees,
● Process evaluation notes
patients, mental health
● Documentation of adverse events and expert trainers, mental
serious adverse events
health service users,
and research staff

Primary care trainees,
patients
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Table 1 Pilot study objectives (Continued)
Domains

Research questions

Hypotheses

Methods

Participants

1-8. Assess the
Do primary care workers’
change in primary
knowledge, attitudes, and
care worker
competence improve?
attitudes, knowledge,
and clinical
competency

Primary care workers in the
RESHAPE intervention arm will
show improvement in
outcomes

● Outcome assessment preand post-training, plus 4and 16-month follow-up

Primary care trainees

1-9. Assess the
change in patient
stigma-related
barriers to care,
functioning, and
symptoms

Patients in the RESHAPE
intervention arm will show
improvement in outcomes

● Pre-treatment assessment
plus 6-month follow-up

Patients

Do patients’ experiences of
stigma, functioning, and
depression symptoms improve?

5. Establish acceptability, feasibility, and validity of
outcome measures;
6. Determine psychometric properties of outcome
measures in a clustered design;
7. Demonstrate ethics and safety of the c-RCT
protocol;
8. Describe changes in primary care workers’ attitudes,
knowledge, and clinical competency;
9. Describe changes in patient-related barriers to care,
functioning, and symptoms.

Methods/design
Setting

The study will take place across 34 healthcare facilities
(each healthcare facility represents one cluster in the
design) in Chitwan district in southern Nepal. Nepal is a
low-income country in Asia and is categorized by the
World Bank as a fragile state [49]. Nepal’s population is
approximately 27 million with the majority (83%) of the
population living in the rural areas [50]. The country
suffered a decade-long civil war from 1996 to 2006 as
well as two major earthquakes in 2015. Previous studies
have demonstrated the impact of political violence on
psychosocial wellbeing and mental health in Nepal,
showing high rates of depression ranging from 17 to
40% since the conclusion of conflict [51, 52]. After the
earthquakes, depression was found to affect one out of
three adults [53]. In Nepal, depression is also associated
with impaired functioning [52, 54], and suicide is the
leading cause of death among women of reproductive
age in Nepal [55]. One out of 10 adults presenting to
primary care services endorses recent suicidal ideation
[56]. This is in the context of limited specialized mental
health services in both Nepal and throughout South Asia
[57]. In 2011, there were fewer than 75 Nepali psychiatrists in clinical practice, with the majority of these working in large urban areas or outside of Nepal in HIC [58].
It is within a context of recent violence and natural
disasters, ongoing poverty, high depression burden, and
lack of mental health services that the UK AID/DFIDsponsored Programme for Improving Mental healthcarE

(PRIME) is being implemented in Chitwan, Nepal, over
the period of 2012–2019 [59]. PRIME aims to improve
the coverage of treatment for priority mental disorders
by implementing and evaluating a comprehensive mental
healthcare package, integrated into primary healthcare in
five LMICs (Nepal, India, South Africa, Ethiopia, and
Uganda) [60–66]. Prior to the implementation of
PRIME, no mental health services were systematically
available in primary healthcare in Nepal [58, 62].
Government health facilities include health posts,
primary health centers, urban clinics, and hospitals.
These are all part of the government health center and
represent the first portal for care. In these facilities,
primary healthcare workers include health assistants,
community medical assistants, and auxiliary nurse
midwives, all of whom are non-specialist with approximate 2 years of medical training. Some health facilities
also include medical doctors with MBBS (bachelor of
medicine/bachelor of surgery) credentials. PRIME and
the RESHAPE component are implemented by Transcultural Psychosocial Organization (TPO) Nepal, a Nepali
non-governmental mental health research and training
organization [67]. The PRIME program is divided into
two phases: implementation and scale-up. During the
implementation phase, the PRIME package of care was
piloted in 12 health facilities in Chitwan [59]. In the scaleup phase, the PRIME program is expanded to the
remaining 34 health facilities in Chitwan district. The
RESHAPE vs. TAU study will take place in all 34 health
facilities participating in the scale-up phase. Additional
information on the study site in Chitwan has been previously published [59].
Design

We will compare TAU to the novel training strategy
(RESHAPE). We will employ a c-RCT in which primary
care health facilities in Chitwan are randomly assigned
to either the TAU or RESHAPE. A healthcare facility
cluster design was selected because attitudes and clinical
behaviors are influenced by peers, and thus, we anticipate a high degree of contamination among primary

Kohrt et al. Pilot and Feasibility Studies (2018) 4:36

healthcare workers within a facility. Moreover, clinical
care is not restricted to exclusive relationships with a
single provider in the government health system. Therefore, patient care will be characterized by seeing a range
of healthcare workers within a single facility over the
course of their treatments. Therefore, a cluster design
with the health facility as the unit of clustering is
required to minimize contamination.
Intervention: training as usual versus training augmented
with the RESHAPE intervention

The TAU arm will include the standard PRIME training
based on the district mental health plan developed for
PRIME in Nepal [59]. There are two versions of the
standard PRIME training: one for prescribers and one
for non-prescribers, a division based on scope of practice
under government care regulations. Prescribers refer to
health workers who can prescribe medication (health
assistants and auxiliary health workers). We have
selected these paramedical staff rather than focusing
exclusively on MBBS-credentialled doctors because not
all primary healthcare facilities have doctors on staff.
Therefore, health assistants and auxiliary health workers
are most often the front-line of primary healthcare.
MBBS doctors are limited to a few primary healthcare
centers and most hospitals and are usually seen after a
person has encountered a lower level cadre of paramedical workers.
Training for prescribers in PRIME is based on the
World Health Organization (WHO) mental health Gap
Action Programme (mhGAP)-Intervention Guide [68]
and includes a range of neuropsychiatric disorders, of
which four were selected for the focus of PRIME in
Nepal: depression, psychosis, epilepsy, and alcohol use
disorder. Psychosocial modules focusing on communication skills, supportive techniques, and health education
are included based on prior curricula and adapted for
Nepal [69]. Training to prescribers is provided over
10 days and delivered by a psychiatrist and an experienced
psychosocial counselor. Following training, the prescriber
group participates in supervision sessions with a psychiatrist, with supervision conducted approximately once
every 3 months.
In the Nepal health system, non-prescribers cannot
prescribe medication and provide community outreach,
assist in vaccination within maternal and child health
programs, and promote treatment adherence. Nonprescribers are predominantly auxiliary nurse midwives.
Within PRIME, non-prescribers deliver psychological
treatments including general psychosocial care, the
Healthy Activity Program (HAP) intervention, which is a
six to eight session behavioral activation psychological
treatment that enhances participants’ uptake of pleasurable and mastery activities with the objective of
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depression symptom reduction, and the Counseling for
Alcohol Problems (CAP) intervention, which is a two to
four sessions simplified and adapted version of motivational interviewing for treatment of alcohol use disorder [70]. Both HAP and CAP have demonstrated
effectiveness for depression and harmful alcohol use
respectively when delivered by non-specialist providers
in India [71, 72]. Non-prescribers receive 5 days of training in psychosocial fundamentals and then a select
group receives an additional 5 days of training in HAP
and CAP. Non-prescribers receive individual on-the-job
supervision from experienced psychosocial counselors.
RESHAPE uses the basic model of PRIME training
and supervision. For both the prescriber (10-day) and
non-prescriber (5-day basic psychosocial plus 5-day
HAP/CAP) training, mental health service users will
participate as co-facilitators. Patients with mental illness
who are in recovery after receiving treatment through
the PRIME original implementation areas will be trained
to serve as mental health service user co-facilitators in
the RESHAPE program in the scale-up health facilities.
Mental health service users are trained to become cofacilitators using “PhotoVoice”—a participatory research
approach in which photography is used to develop testimonials and other messaging [73–76]. PhotoVoice has
previously been used with illiterate women with depression in rural Nepal [77]. Service user co-facilitators in
RESHAPE provide personal testimonials, ongoing social
contact, and myth busting and exemplify a recovery
emphasis [42]. In addition, a health worker who has
previously participated in the PRIME program (in the
original implementation health facilities) receives training to participate as a co-facilitator and serves as an
enthusiastic and aspirational role model [42]. The
rationale for the aspirational figure is to provide a linkage between the current identity of the primary care
trainees and the role they would like to achieve by the
end of the training. Table 2 describes the key elements
of the RESHAPE intervention.
Patients in both the TAU and RESHAPE arms receive
the same intervention package (mhGAP plus psychosocial
services, HAP, and CAP). No elements of the treatment
will vary based on intervention arms. If patients require
greater levels of care than those provided through the
mhGAP-trained primary healthcare workers, patients in
either arm can be referred to psychiatrists at the local psychiatric specialty service for any concerns related to diagnosis,
medication
management,
or
psychiatric
emergencies. Patients are not discontinued from either
treatment arm if referral is required and can continue to
participate in follow-up evaluations. Patients are included
in the current pilot study because we plan to test whether
the RESHAPE training paradigm leads to improved patient outcomes in the subsequent full-scale effectiveness
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trial. Specifically, in the subsequent full trial, we will evaluate if RESHAPE-trained primary healthcare workers have
greater clinical competency and deliver mhGAP, HAP, and
CAP with greater quality resulting in better patient functioning and greater symptom reduction in depression
(HAP participants) and harmful drinking (CAP
participants).

MBBS doctors are working at primary healthcare centers
and included in the training, they will also participate in
the RESHAPE pilot trial. Any patient receiving PRIME
services will be invited to participate. This includes persons with diagnoses of depression, psychosis, alcohol use
disorder, or epilepsy made by prescribers using mhGAP
guidelines.

Participants

Exclusion criteria

For the pilot c-RCT, we plan to recruit all primary
healthcare workers (approximately 150 including prescribers and non-prescribers) who are participating in
the PRIME scale-up phase health facilities (k = 34 facilities), and a subset of their patients, approximately 100
(see Fig. 2). The health facilities will include 32 primary
care centers and 2 hospitals providing primary care services. Primary healthcare workers are the intended direct
beneficiaries of RESHAPE. Their patients are the
intended indirect beneficiaries. In the pilot, additional
participants will include mental health service users who
will be trained as facilitators for RESHAPE, mental
health experts (psychiatrists and psychosocial counselors) who serve as facilitators and supervisors, and research staff (research assistants, field coordinators, and
external competency and fidelity raters).

Primary healthcare workers who do not have appropriate
government credentialing will be excluded. Patients who
are personally unable to complete the research interview
as well as those lacking caregivers able to assist with the
assessments will be excluded.

Inclusion criteria

All primary healthcare workers (approximately 150) participating in either the prescriber (10-day mhGAP) or
non-prescriber (5-day basic psychosocial with some
non-prescribers also participating in the 5-day additional
HAP/CAP training) PRIME trainings will be invited to
participate. We anticipate the majority of primary
healthcare workers will be paramedical staff. However, if

Measures/outcomes for feasibility criteria and other
objectives

The primary objective is to evaluate feasibility and acceptability (see the “Objectives” section). In accordance
with recommendations for pilot study reporting [48], we
have established qualitative and quantitative indicators
to guide decisions about what procedures to carry
through to the full trial and when modifications should
be made. Acceptability and feasibility will be evaluated
through qualitative interviews and focus group discussions with primary care health workers. Other qualitative
topics will be acceptability and feasibility of taking on
mental health services. Adoption of mental health services will be measured as the amount of mental health
services (e.g., number of outpatient visits) provided in
the primary care facilities. The other objectives will be to
evaluate fidelity, randomization, recruitment and retention, acceptability and feasibility of measures, instrument
statistical characteristics, and ethics and safe conduct of

Table 2 Elements of RESHAPE intervention
RESHAPE elements

Description of element content

Implementation of element

Engagement with
service users

Opportunities for socialization, participation in practice role plays,
collaborative problem solving

Included during multiple days of training

Testimonial from
service users

Three-part testimonials developed through PhotoVoice training
using photographs and personal stories to describe life before
treatment, the experience of treatment, and life after treatment

Testimonials provided separately for target disorders:
depression, psychosis, alcohol use disorder, and epilepsy

Testimonials from
aspirational figures

Three-part testimonials describing experiences and attitudes prior
to mental health training, experiences of providing mental
healthcare, and changes in attitude and behavior after starting
delivery of mental health services

One or two testimonials from health workers who
previously participated in PRIME training and mental
health service delivery

Myth busting

Eight common myths: mental illness cannot be treated; only some
people can get mental illness; mental illnesses are contagious;
mental illness can only be treated with shots and pills; giving
advice is the same thing as doing psychological counseling; all
people with mental illness are violent; if you ask someone about
suicide, that increases the risk they will kill him/herself; caring for
people with mental illness makes you mentally ill

Delivered in one session by one aspirational primary care
worker

Didactic session on
stigma and
discrimination

Definitions of stigma and discrimination; reasons for stigma and
discrimination; addressing different causes of discrimination: peril
stigma, occupational stigma, and social stigma

Delivered in one session by a trained facilitator
working for the PRIME implementation NGO (TPO Nepal)

Kohrt et al. Pilot and Feasibility Studies (2018) 4:36

Page 8 of 18

Fig. 2 Flow chart for RESHAPE pilot cluster randomized controlled trial. Flow diagram for progress of health facility clusters and primary healthcare
workers (PCW). Gray boxes represent patient flow. Abbreviations: PRIME Programme for Improving Mental healthcarE, RESHAPE Reducing Stigma
among HealthcAre Providers to ImprovE mental health services, mhGAP mental health Global Action Programme, HAP Healthy Activity Programme,
CAP Counseling for Alcohol Problems

the trial. Taking these objectives together, overall feasibility and acceptability will be determined by the following criteria to determine progression to the full trial:
a) Identification of qualitative themes reporting that
service user co-facilitation benefits acquisition and
implementation of knowledge, instills positive attitudes toward persons with mental illness, e.g., “see the
person” messages, messages that “mental illnesses are
treatable”, and “recovery messages,” [78] and the absence of themes that service users are perceived as
disruptive. Among service users, the qualitative data
will be coded for themes that participation is empowering or enhancing self-efficacy, that participation does
not damage familial or community relations, that participation is perceived as safe, and that participation is
not perceived as stressful resulting in worsening mental health (domain 1-1)
b) Fidelity to 75% of items on the fidelity checklist for
RESHAPE elements (domain 1-2)
c) Tabulation of descriptive summaries for baseline
characteristics comparing two groups of primary
care workers demonstrating no significant group
differences in educational/professional qualifications,
age, gender, primary mental health exposure, and
years of experience (domain 1-3)

d) Retention of at least 50% of mental health service
users as facilitators in the RESHAPE trainings, 66%
completion of 16-month follow-up by health
workers, and 66% follow-up of patients (domain 1-4)
e) Fewer than 15% missing items on outcome measures
(domain 1-5)
f ) Presence of adverse events among fewer than 10%
of participants and any serious adverse events
(domain 1-7)
In domains where criteria are met, we will retain the
procedure for the full trial. In domains where criteria are
not met, we will modify procedures for the full trial. The
presence of any adverse events and serious adverse
events will be addressed by the trial team to identify
alternative strategies for the full trial.
In addition, there are two objectives related to gathering pilot quantitative data for both primary healthcare
workers’ and patients’ outcomes (domains 1-8 and 1-9 in
Table 1). For these outcomes, we will complete descriptive reports of reduction in mental illness stigma among
primary healthcare workers operationalized as a reduction in social distance scales, which is the intended primary outcome of the subsequent full trial. The primary
outcome for the eventual full study is the Social Distance
Scale (SDS) previously used in another study in Nepal
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biases will be assessed with a computer-based implicit
association test (IAT) [82] adapted for use with stimuli
appropriate for Nepali health workers [83]. Competence
will be assessed through standardized role plays with
mock patients. The role plays will be scored with the
ENhancing Assessment of Common Therapeutic factors
(ENACT) rating scale. ENACT was developed in Nepal
within PRIME [84, 85]. In addition, psychiatrists will
interview a subset of patients diagnosed by primary
healthcare workers. The psychiatrists will use the Composite International Diagnostic Interview (CIDI), which
has been validated in Nepal [86], to establish a diagnosis
and then compare with the primary healthcare worker’s
diagnosis and treatment recommendations as a measure

and based on select sections of the instrument used in
the Stigma in Global Context—Mental Health Study
[79–81]. The Nepali version of the SDS for healthcare
workers has 12 items and usage in PRIME prior to the
RESHAPE study found that the SDS has strong internal
consistency (α = 0.80). Secondary health worker outcomes for the full trial include knowledge, implicit
biases, and clinical competency (see Table 3). There will
also be a range of secondary outcomes for primary
healthcare workers. A secondary measure of stigma will
be the mhGAP attitude battery previously used in
PRIME in Nepal and other global PRIME sites. Similarly,
the PRIME mhGAP knowledge assessment (multiple
choice and true-false questions) will be used. Implicit
Table 3 Pilot c-RCT outcome measures
Construct

Instrument

Description

Assessment time periods
4-month
16-month
Patient Patient 6-month
Pre-training Immediate
post-training post-training post-training baseline follow-up
(t1)
(t3)
(t4)
(t5)
(t6)
(t2)

Primary outcome (primary healthcare workers)
Stigma

Social distance

Primary healthcare workers selfrate level of social distance related
to interacting with persons with
mental illness

X

X

X

X

Secondary outcomes (primary healthcare workers)
Mental
healthcare
knowledge

mhGAP knowledge

Primary healthcare workers
complete multiple choice and
true/false questions reflecting
knowledge of mental health
diagnoses and treatment

X

X

X

X

Stigma

mhGAP attitudes

Primary healthcare workers
complete questions regarding
attitudes toward people with
mental illness

X

X

X

X

Stigma

Implicit Association Test (IAT)

Primary healthcare workers
complete a computer-based
neuropsychological test assessing
implicit biases related to mental
illness and violence

X

X

X

Clinical
Enhancing Assessment of
competency Common Therapeutic Factors
(ENACT)

Competency is rated by
observers through role plays
between primary healthcare
workers and standardized
patients

X

X

X

Diagnostic
and
treatment
fidelity

Psychiatrists administer the CIDI
to patients diagnosed by primary
healthcare workers and compare
with the diagnosis and treatment
recommendations

X

Patients rate degree to which
stigma is a barrier to care seeking

X

X

Patients rate their primary
healthcare workers on quality of
common factors in care

X

X

Psychiatrist administered
Composite International
Diagnostic Interview (CIDI)

Secondary outcomes (patients)
Stigma and
care access

Barriers to Access to Care
Evaluation (BACE)

Perceived
Enhancing Assessment of
clinical
Common Therapeutic Factors
competency (ENACT)—patient rating version
Daily
functioning

WHO Disability Assessment Scale Patients rate ability to perform
(WHODAS)
daily functioning

X

X

Depression
symptoms

Patient Health Questionnaire
(PHQ-9)

Patient rate depression symptoms
over past two weeks

X

X

Alcohol use
disorder

Alcohol Use Disorders
Identification Test (AUDIT)

Patients rate alcohol use and
associated behavior, as well as
daily ethanol consumption

X

X
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of treatment fidelity. We will also attempt to contact primary healthcare workers who drop out of the study (e.g.,
get reassigned to another health facility, retire, change
profession) for quantitative and qualitative interviews to
assess impact of TAU vs. RESHAPE on subsequent professional activities.
Outcomes for patients include stigma-related barriers
to accessing care, daily functioning, and symptoms.
These are descriptive analyses to inform potential effectiveness which will be evaluated in the eventual full trial.
Patients will be evaluated after completion of the primary healthcare worker's initial consultation. This will
allow time for the primary healthcare workers to develop
their treatment skills and ideally for the skills to
stabilize. For patient measures, the Barriers to Access to
Care Evaluation (BACE) [87] will be used to evaluate the
severity of stigma associated with seeking care. BACE is
used currently for PRIME in Nepal. The WHO Disability
Assessment Scale (WHODAS) [88] has been used previously in Nepal [54, 89, 90], with excellent internal
consistency between items (α = 0.90) and strong validity
with multiple mental health measures for depression (r
= 0.70, p < 0.001), anxiety (r = 0.64, p < 0.001), and PTSD
(r = 0.37, p < 0.001). The Patient Health Questionnaire
(PHQ-9) [91] has been transculturally translated and
clinically validated in Nepal [92]. Harmful alcohol drinking will also be assessed with the AUDIT [93], which has
previously been used in Nepal [94, 95], as well as daily
ethanol consumption. Patients will also complete a
patient-rating version of the ENACT to evaluate the
primary healthcare worker’s competency in common
clinical factors. Patient data collection will be completed
using Open Data Kit [96] on Android tablets. Patients
who discontinue care will be followed up at the end of the
study for both quantitative and qualitative assessments.
This is an external pilot, and therefore, we will not
carry quantitative data from the health worker and
patient outcomes into the full trial. In accord with
recommendations for a priori determination of carrying
data forward from pilots to full trials [97, 98], we have
determined that contextual and implementation preclude a carry-forward design. The justification for this is
that the current pilot is embedded with the larger
PRIME initiative in Chitwan, Nepal [59], which is likely
to influence outcomes beyond the focus on RESHAPE
training models. Because PRIME has gone through iterative development in Chitwan, different approaches to
training, supervision, and evaluation have been used.
The full trial will be conducted in naïve sites that have
not gone through the PRIME development process.
Randomization

There are 34 health facilities (clusters) in the PRIME
scale-up regions of Chitwan. Health facilities will be the
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selected unit of randomization because they generally
function independently from one another. We will
examine baseline differences in patients. If there are
baseline differences, we will adjust for this variable (e.g.,
distance from clinic) in the analytical approach. The
allocation ratio for health facilities is 1:1. All health
workers attending the trainings will be enrolled by TPO
research staff. Randomization of health clusters will be
performed by the study statistician (ELT) using a random number generator in Stata version 14 software [99].
Health facilities will be notified regarding the dates for
their training, but they will be blinded to whether the
training is a PRIME or RESHAPE training. Potential
sources of contamination across arms are the movement
of health workers from a facility in one to a facility in
another arm and the movement of patients from
residence in one arm’s catchment to a residence in
another catchment. These sources of potential contamination will be monitored and addressed in the design of
the subsequent full-scale effectiveness trial after completion of this pilot.
Recruitment

All primary care trainees in PRIME are expected to
participate in pre- and post-training plus follow-up
evaluations as a condition of their training participation,
which is coordinated with the local government
through the district public health office. A subset of
trainees will be randomly selected to participate in
the qualitative component of the study, and this
participation is elective. All patient participation is
voluntary, and recruitment takes place after patients
receive any mhGAP diagnosis from a primary care
provider in the study.
Blinding and concealment

Primary healthcare workers will be blinded to the
condition of training. They will not be informed
ahead of time that the main variation in trainings is
the presence of mental health service users as cofacilitators, as this may bias their responses. Research assistants will be blinded to the training arm,
and psychosocial counselors who perform ENACT
evaluations will be blinded to the arm. Raters who
evaluate the ENACT recordings will be blinded to
both treatment arm and to which period of the
training and supervision the evaluation is from. No a
priori unblinding specifications are established for
primary healthcare workers given that the two implementation arms are not associated with different
levels of risk. Unblinding is not relevant for patients
given that they will be receiving the same intervention. Study statisticians will be blinded to treatment
arm during analyses.
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Sample size

The 34 health facilities are staffed by approximately
80 prescribers and 70 non-prescribers. The sample is
selected based on feasibility with the PRIME scale-up
region of Chitwan. Sample size was not determined
based on inference testing given the pilot design of
this study [100]. Approximately 100 patients will be
enrolled in the patient outcome component. Patient
sample size was based on calculations performed for
a quality of care study previously planned for PRIME
scale-up. Specifically, the target number of patients is
86, for which we will recruit and enroll 100 participants, assuming limited attrition. With a sample of n
= 86, in which 80% of them receive appropriate diagnosis and initial treatment, the 95% CI will be 70.2 to
88.0%; allowing for some over-sampling, we are aiming for n = 100. The sample size is based on precision
calculation and assumes a simple random sample
from all diagnosed patients.
Financial incentives

As per government regulations, primary healthcare
workers are paid approximately US$16 per day to attend
trainings. In addition, they receive transportation, food,
and lodging funds. PRIME will cover these costs for
health workers. Similar payments are made for the
supervision sessions. Patients are not financially compensated but they are provided with transportation cost,
food and lodging when required. Health workers and patients are provided with some form of non-financial
compensation (e.g., household gift items) if they are participating in the qualitative interviews outside the training days.
Data management and monitoring

All investigators on the study will have access to primary data. TPO Nepal research supervisors will do
quality assurance checks on data collected by research
assistants. Data will be stored in both offline and
cloud repositories in compliance with data security
recommendations of the institutional review boards
involved in the study. Storage platforms will include
HIPAA-compliant REDCAP and Box. A Data and
Safety Monitoring Board (DSMB) has been established
in Nepal for oversight of TPO trials including PRIME
and RESHAPE. DSMB members include psychiatrists,
legal experts, non-governmental organization experts
in psychosocial programs, and mental health advocates. No DSMB board members are study staff of
PRIME or RESHAPE. Given that this is a pilot c-RCT
that is not powered for inference testing, interim statistical analyses with associated stopping guidelines are
not planned.
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Planned analyses
Qualitative analyses

Focus group discussions (FGDs), key informant interviews, and process evaluation notes will be coded in
NVIVO [101] and analyzed using content analysis
[102] for themes of cultural acceptability, experience
of consumers as trainers, relevance to clinical care,
training duration, structure of training, content of
training, and follow-up engagement, following approaches used in similar global mental health studies
[103]. Coding will be done by multiple independent
raters, and inter-rater reliability will be calculated
using Kappa scores. Data analysis will be conducted
throughout each step to facilitate iterative revision
then finalization of the manual. Following the Consolidated Criteria for Reporting Qualitative Studies
(COREQ), we will document the process according to
the 32-item checklist [104]. Broadly, for domain 1
“research team and reflexivity,” the qualitative
research team will include the PI, TPO staff, and
research trainees; the degrees will range from MD
and PhD to MA and Bachelors; the occupations will
include academic medical faculty, NGO staff, and
students; there will be both male and female qualitative staff, and staff experience in qualitative research
will range from 1 month to greater than 10 years; the
relationship with participants will not precede the
study; participants will know that research staff are
employed by or associated with TPO Nepal, and
interviewer characteristics (age, education, region of
origin, etc.) will be reported. For domain 2 “study
design,” content analysis will be used; selection will
be reported as described above; setting features
including location and presence of non-participants
will be reported; an interview guide will be used;
there will be repeat interviews at different times in
the training and supervision timelines; audio will be
recorded; duration will be documented; data saturation or lack thereof will be reported; and transcripts
will not be returned to participants for analysis. For
domain 3, there will be approximately four to six
coders; the coding tree will be published; themes will
be identified in advance with the option to generate
additional themes; participants will not provide feedback on the coding; quotations will be presented; data
and findings will be consistent; and major and minor
themes will be clearly presented.
Statistical analyses

The quantitative outcomes of interest will be summarized descriptively using appropriate summary statistics
(mean and standard deviation for continuous outcomes
and numbers and proportions for categorical outcomes)
and graphically over time for the primary healthcare
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workers (four time points: pre- and post-training,
4 months-, and 16 months-post-training) and patients
(two time points: treatment entry and 6 months later)
for both study arms. Provider and patient trends over
time for each score will be plotted to examine betweenand within-person differences and to determine the
plausible pattern (e.g., linearity) of those trends. The
profiles will be grouped by cluster (the health facility)
and by study arm to examine between-cluster and
between-arm variation in provider and patient outcomes.
Using the first measurements for provider (i.e., prior to
beginning the mhGAP training) and patient (i.e., after
the first diagnostic visit with an mhGAP-trained primary
care provider), preliminary estimates of within- and
between-cluster variances, within- and between-primary
care worker variances and the intra-class correlation coefficient (ICC) of patient outcomes will be estimated.
Such estimates are essential for sample size calculations
for the planned full-scale c-RCT design and are often
guessed or obtained from other studies, whereas we will
obtain context and design-specific estimates using our
pilot data [105, 106]. Nevertheless, as noted by Eldridge
et al. [105], there are concerns that sample size estimates
based on these pilot data could be too small. Because we
will collect individual-level data from 34 clusters, our
pilot c-RCT size should mitigate some of these concerns.
Nevertheless, we plan to power the full trial based on
more conservative estimates of the parameters of interest than those obtained from the pilot c-RCT by using
the upper bound of the 95% CI for the ICC and by comparing our estimates to those from other studies of similar outcomes to be sure we will increase our estimates if
we find them to be considerably smaller than those from
other studies. By using such a “triangulation” approach
and by obtaining context-specific data, we are confident
that we will be able to better design the full-scale c-RCT
than in the absence of the pilot c-RCT data. The pilot
data will also be used to inform the choice of effect estimate (e.g., difference in slopes or in means at a specific
follow-up time point) in the future c-RCT that will build
on the current pilot study. Preliminary indicative
estimates of differences in primary and secondary outcomes by arm will be obtained. In practice, we will
power the future c-RCT predominantly based on magnitudes of effect that are of public health relevance rather
than using magnitudes of effects obtained from the pilot
study, which will not necessarily be indicative of what
could be attained in an appropriately powered larger
c-RCT.
Mixed methods framework

This pilot study will follow the Good Reporting of A
Mixed Methods Study (GRAMMS) guidelines [107]:
First, mixed methods are being used to evaluate
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feasibility and acceptability qualitatively while quantitative information will be used for the design of the
full trial. Second, qualitative and quantitative will be
assessed generally during the same intervals of the
study. Focus group discussions will be conducted preand post-trainings around the timing of pre- and
post-quantitative assessments. Similarly, follow-up qualitative and quantitative assessments will occur after a few
months of practice and 1 year later. Third, both methods
will be clearly documented in publications with regard to
sampling, data collection, and analysis. Fourth, integration will occur in regard to health workers qualitative
descriptions of their stigma, knowledge, and competency, which will be integrated with quantitative
scores on these three variables. Fifth, because this is a
pilot study, inference testing on the quantitative data
are limited; therefore, we cannot compare qualitative
and quantitative data with regard to effectiveness of
the RESHAPE program. Sixth, insights resulting specifically from integration of qualitative and quantitative findings will be highlighted.
Ethics and research governance
Consent

Consent follows current models within PRIME wherein
health supervisors nominate primary healthcare
workers for the training. In this case, we are following
the ethic of beneficence in that primary healthcare
workers are required to attend the training (whichever
variant) because to not attend the training would deny
their patients access to mental healthcare. However, all
primary healthcare workers will be given the opportunity to refuse participation in the research process and
follow-up while still participating in training. This is in
accord with approaches others have taken in c-RCTs to
assure that patients are not denied care: “if a health
care professional chooses not to participate in a study,
they are in effect denying their patients the potential
benefits of participation. Healthcare providers ought to
do the best for their patients,” [108]. For patients, we
will follow a similar model in which all patients are
consented for participation in the data collection
process and follow-up, and participation in treatment is
not contingent upon research participation. This is
because these health facilities currently lack professionals with mental health training. Therefore, to give
the patient the option of not participating with a
primary care worker trained through PRIME equates to
denying care, i.e., current treatment as usual is no treatment at all. Therefore, at a minimum, all patients
presenting to clinics within the clusters will have access
to basic mental healthcare through PRIME-trained
primary healthcare workers regardless of consent or
refusal to participate in the data collection process. Any
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codes linking participant information to personal identifiers or personal health information will be restricted to
the TPO Nepal research supervisor. Only de-identified
data will be used for analyses.
Harms

The main risk factor is psychological distress among
mental health service users trained to co-facilitate
trainings. If mental health service users acting as cofacilitators do not feel that the training is a comfortable
environment, we have outlined contingency plans regarding use of videotaped testimonials and provision of
stand-by counselor to provide immediate care to the
mental health service users when required. Given a
prior training with healthcare consumers in Nepal, we
anticipate that consumers will find the training experience a non-distressing experience. Minimal risk of
harm from the treatment is anticipated. In addition to
these risks with greatest likelihood, another issue to
consider is the negative consequences if confidentiality
of information obtained in the study (including subject
identity as a research participant or information collected during assessments) were compromised.
Treatment may include psychotherapy and/or medication management. All patients are expected to be receiving optimal clinical care at the clinical judgment of
primary healthcare workers. Primary healthcare workers
are supervised by psychiatrists in Chitwan who can provide information on management and receive referrals
for patients with worsening symptoms or other clinical
concerns.
All changes in treatment resulting from adverse events
or serious adverse events will be reported to the DSMB
in Nepal. TPO Nepal is responsible for data collection
and storage and making data available to the DSMB,
funders, and IRBs for audits when appropriate.
Post-trial care

Primary healthcare workers will remain in the region to
continue care after the trial pending any transfers by the
government. The government has agreed to update the
essential medication list so that patients can get access
to medications after the trial. Currently, medications are
purchased by PRIME and the specific medication and
brands are dictated by the the updated essential
medication list and supply preferences by the
government.
Dissemination

Findings from the pilot study will be published in academic journals, disseminated through the PRIME network, reported to funders of PRIME (United Kingdom
Agency for International Development, UKAID) and RESHAPE (United States National Institute of Mental
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Health, NIMH). Authorship eligibility will comply with
guidelines of the International Committee of Medical
Journal Editors, with additional attention to
recommendations for equitable representation of researchers from LMIC for academic authorship [109].
The materials for training and implementation of RESHAPE will be made available through the Mental
Health Innovation Network (www.mhinnovation.net). In
keeping with NIMH recommendations, data will be made
publicly available after publication of primary analyses.
Timescale

Primary healthcare workers will be followed for 2 years
from 2016 to 2018 to evaluate retention, changes in
knowledge, attitudes, and clinical competence. Patients
will be enrolled approximately 18 months after primary
healthcare workers are trained. They will be followed-up
6 months after initial enrollment evaluation. Data collection will be completed by the end of June 2018. See
Table 4 for schedule of enrollment, interventions, and
assessments.

Discussion
The results of the pilot trial will be used to determine
if we can move forward with the same procedures for
the full trial in another region of Nepal. If there are
qualitative or quantitative indicators of problems with
feasibility and acceptability impacting recruitment,
retention, randomization, fidelity, or safety, those
relevant procedures will be modified. This is an
external pilot study, and therefore, data will not be
carried forward from this pilot to the full trial. If significant modifications are needed, we will consider
the need for an internal pilot in the context of the
full trial [97].
There is growing evidence that improving provider
attitudes and competence through adding social
contact with mental health service users throughout
training and supervision increases the likelihood that
mental health interventions are scaled up and delivered with fidelity. If shown to be effective, the implications of our results are not limited to Nepal but
also have relevance for improving use and quality of
EBP for global mental health in LMIC and high-income settings because adopting EBP and enhancing provider motivation are global challenges [110–112].
Developing implementation strategies to reduce stigma is
consistent with objectives of the WHO Action Plan 2013–
2020 [113] and a goal of the Grand Challenges in Global
Mental Health [114].
Trial status

The trial is open and recruiting. The protocol was last verified on 24 July 2017. Subsequent protocol modifications
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Table 4 Schedule of enrollment, interventions, and assessments for RESHAPE
Study period
Primary healthcare workers (direct beneficiaries)—trained to deliver mental health services

Time point

Cluster allocation

Enrollment

Post-allocation

-t1

t0

t1

t2

Close-out
t3

t4

t5

t6

Enrollment
Allocation

X

Eligibility screen

X

Informed consent

X

Interventions
PRIME training and supervision (TAU)

←−−−−−−−−−−−−−−−−−−−−−−−−−−→

RESHAPE training and supervision

←−−−−−−−−−−−−−−−−−−−−−−−−−−→

Assessments
mhGAP knowledge

X

X

X

X

mhGAP attitudes

X

X

X

X

Social Distance

X

X

X

X

Implicit Assoc. Test

X

X

X

X

Health worker—ENACT

X

X

X

X

Qualitative interviews

X

X

X

X

Patients (indirect beneficiaries)—patients treated by TAU or RESHAPE-trained primary healthcare workers

Time point**

Cluster Allocation

Post-allocation

-t1

t1

t2

Close-out
t3

t4

t5

t6

Enrollment
Allocation

X

Eligibility screen

X

Informed consent

X

Interventions
mhGAP + HAP/CAP

←−→

Assessments
Patient—BACE

X

X

Patient—WHODAS

X

X

Patient—PHQ-9

X

X

Patient—AUDIT

X

X

Patient—ENACT

X

Qualitative interviews

X
X

Note: All health facility clusters are allocated are -t1. Primary healthcare workers are assigned to Training As Usual (TAU) or RESHAPE trainings based on the health
facility in which they work. Primary healthcare workers are enrolled and consents at t0. Primary healthcare workers are administered assessment batteries
immediately prior to training at t1. They then participate in training and subsequent supervision for the duration of the research study. There is an immediate
post-training assessment at t2, followed by a 4-month (t3) and 16-month (t5) assessment. Close-out qualitative interviews are conducted with a subset of primary
healthcare workers at t6. Patients are enrolled with TAU or RESHAPE-trained primary healthcare workers according to the allocation of their local healthcare facility.
They all receive mhGAP and HAP/CAP interventions. Patient enrollment occurs at approximately 18 months after primary healthcare workers are trained. Patients
are assessed at treatment initiation (t5) and 6 months later at study close-out (t6). Close-out qualitative interviews are conducted with a subset of patients at t6

will be reported to funders, IRBs, and registered with ClinicalTrials.gov. Modifications made since original submission
of the grant proposal to NIMH were instituting a posttraining follow-up at 4 months because lack of medication
release by the government precluded initiation of services.
With the use of the 4-month follow-up, the 6-month

follow-up was removed because it was too close in
time to the 4-month assessment. In addition, because
of the delay in initiation of services, the final quantitative follow-up of healthcare workers was modified
to 16 months, to coincide with approximately 1 year
of service delivery.
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